The Impact of Culture in Cognitive Behavior Therapy (CBT) for Patients With Inflammatory Bowel Disease

Launched by WANG ZHEN · Nov 27, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how cultural factors affect the use of Cognitive Behavioral Therapy (CBT) for patients with Inflammatory Bowel Disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. IBD can greatly impact a person’s quality of life and mental well-being, and CBT is a type of therapy that can help with the psychological challenges linked to these chronic conditions. The goal of this study is to better understand how different cultural backgrounds can influence the effectiveness of CBT and to help tailor this therapy so that it works well for IBD patients from various cultures.

To participate in this trial, individuals must be at least 18 years old, have a diagnosed case of IBD, live in China, and be able to communicate in Chinese. They should be willing to attend six online therapy sessions that last one hour each and should not have changed their antidepressant medication in the three months before the trial starts. Participants can expect to engage in discussions and activities designed to improve their mental health while considering their cultural beliefs and values. This research is important because it aims to make mental health care for IBD patients more effective and accessible for everyone, regardless of their cultural background.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients over 18 years of age with diagnosed IBD.
• • 2. Age: 18 years and older.
• • 3. residing in China, able to verbally communicate and read in Chinese, with access to the internet to ensure participation in the online intervention.
• • 4. Able to commit to attend the 6weekly sessions of 1 hours' duration.
• • 5. No change in antidepressant medication (dose or type) within 3 months of trial onset.
• Exclusion Criteria:
• • 1. Individuals scheduled for major surgery in the next 3 months.
• • 2. Current psychological treatment.
• • 3. Individuals with severe schizophrenia/psychotic disorder.